tiprankstipranks
Trending News
More News >
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Income Statement

Compare
59 Followers

Climb Bio Income Statement

Last quarter (Q4 2024), Climb Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Climb Bio's net income was $-8.42M. See Climb Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 82.02M$ 40.27M$ 45.13M$ 35.67M$ 20.93M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -30.36M$ -40.27M$ -45.13M$ -35.67M$ -11.77M
Operating Income
$ -82.02M$ -40.27M$ -45.13M$ -35.67M$ -20.93M
Other Income/Expenses
$ 8.12M$ 5.16M$ -109.00K$ -11.81M$ 257.00K
Pretax Income
$ -73.90M$ -35.12M$ -45.24M$ -47.48M$ -20.67M
Net Income
$ -73.90M$ -35.12M$ -45.24M$ -47.48M$ -20.67M
Per Share Metrics
Basic EPS
$ -1.14$ -1.30$ -1.72$ -4.24$ -1.97
Diluted EPS
$ -1.14$ -1.30$ -1.72$ -4.24$ -1.97
Weighted Average Shares Outstanding
64.74M 26.99M 26.31M 12.26M 11.66M
Weighted Average Shares Outstanding (Diluted)
64.74M 26.99M 26.31M 12.26M 11.66M
Currency in USD

Climb Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis